Protocol Ledger

NCT06867705 · Phase III · RECRUITING

Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only

Interventional Phase III clinical trial protocol NCT06867705 sponsored by Resilience in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-04-01 Enrollment: 1,458 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06867705
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,458 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06867705
Protocol FieldVerified Registry Value
NCT IdentifierNCT06867705
Consolidated Lead SponsorResilience
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,458 participants (ESTIMATED)
Registered Start Date2025-04-01
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI